OVERSEA CHINESE BANKING Corp Ltd decreased its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 20.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 20,043 shares of the semiconductor company’s stock after selling 5,257 shares during the quarter. OVERSEA CHINESE BANKING Corp Ltd’s holdings in Synopsys were worth $9,728,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Kieckhefer Group LLC bought a new position in shares of Synopsys in the fourth quarter valued at approximately $27,000. Whipplewood Advisors LLC bought a new position in Synopsys during the 4th quarter valued at $33,000. Sierra Ocean LLC purchased a new position in Synopsys during the 4th quarter worth $39,000. Newbridge Financial Services Group Inc. bought a new stake in shares of Synopsys in the 4th quarter worth $51,000. Finally, Versant Capital Management Inc raised its holdings in shares of Synopsys by 109.3% in the fourth quarter. Versant Capital Management Inc now owns 113 shares of the semiconductor company’s stock valued at $55,000 after purchasing an additional 59 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Price Performance
Synopsys stock opened at $447.99 on Wednesday. Synopsys, Inc. has a one year low of $425.73 and a one year high of $624.80. The firm has a market capitalization of $69.27 billion, a P/E ratio of 30.85, a PEG ratio of 3.23 and a beta of 1.16. The business has a fifty day moving average price of $494.15 and a 200-day moving average price of $507.35.
Insider Activity
Wall Street Analysts Forecast Growth
A number of equities research analysts have issued reports on the stock. Robert W. Baird reduced their price objective on shares of Synopsys from $644.00 to $630.00 and set an “outperform” rating for the company in a research report on Thursday, December 5th. Needham & Company LLC reaffirmed a “buy” rating and issued a $650.00 target price on shares of Synopsys in a report on Thursday, February 27th. Morgan Stanley dropped their price target on Synopsys from $625.00 to $590.00 and set an “overweight” rating on the stock in a report on Monday, February 24th. Redburn Atlantic assumed coverage on Synopsys in a research note on Monday, January 13th. They issued a “buy” rating and a $600.00 price objective for the company. Finally, Rosenblatt Securities reiterated a “buy” rating and set a $660.00 target price on shares of Synopsys in a research note on Tuesday, February 25th. One analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $638.58.
Check Out Our Latest Analysis on SNPS
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Stories
- Five stocks we like better than Synopsys
- How to Invest in Biotech Stocks
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Canadian Penny Stocks: Can They Make You Rich?
- 3 Must-Own Stocks to Build Wealth This Decade
- How to Choose Top Rated Stocks
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.